Neuronal prostacyclin receptors

Progress in Drug Research

Volumn 49, Issue , 1997, Pages 123-154

  Wise, Helen ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTACYCLIN RECEPTOR;

CENTRAL NERVOUS SYSTEM FUNCTION; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL; NERVE FUNCTION; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SENSORY NERVE CELL; SPINAL GANGLION; VASCULAR ENDOTHELIUM;

EID: 0030836310     PISSN: 0071786X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-0348-8863-9_4     Document Type: Review

References (126)

1. S. Moncada: Br. J. Pharmacol. 76,3-31 (1982).
2. M. Hirata, F. Ushikubi and S. Narumiya: J. Lipid Mediators Cell Signal. 12, 393-404 (1995).
3. P. Needleman, J. Turk, B.A. Jakschik, A.R. Morison and J.B. Lefkowith: Annu. Rev. Biochem. 55, 69-102 (1986).
4. R.A. Coleman, W.L. Smith and S. Narumiya: Pharmacol. Rev. 46, 205-229 (1994).
5. L. Wang and L. Chen: Biochem. Biophys. Res. Commun. 226, 631-637 (1996).
6. T.Tanabe and V. Ullrich: J. Lipid Mediators Cell Signal. 12, 243-255 (1995).
7. Y.J. Dong, R.L. Jones and N.H. Wilson: Br. J. Pharmacol. 87, 97-107 (1986).
8. R.A. Lawrence, R.L. Jones and N.H. Wilson: Br. J. Pharmacol. 105, 271-278 (1992).
9. Y. Kawai and T. Ohhashi: Br. J. Pharmacol. 112, 635-639 (1994).
10. R.L. Jones, N.H. Wilson, C.G. Marr, G. Muir and R.A. Armstrong: J. Lipid Mediators Cell Signal. 6, 405-410 (1993).
11. N.A. Meanwell, J.L. Romine and S.M. Seiler: Drugs of the Future 19, 361-385 (1994).
12. T. Namba, H. Oida, Y. Sugimoto, A. Kakizuka, M. Negishi, A. Ichikawa and S. Narumiya: J. Biol. Chem. 269, 9986-9992 (1994).
13. Y. Boie, T.H. Rushmore, A. Darmon-Goodwin, R. Grygorczyk, D.M. Slipetz, K.M. Metters and M. Abramovitz: J. Biol. Chem. 269, 12173-12178 (1994).
14. M. Katsuyama, Y. Sugimoto, T. Namba, A. Irie, M. Negishi, S. Narumiya and A. Ichikawa: FEBS Lett. 344, 74-78 (1994).
15. O. Nakagawa, I. Tanaka, T. Usui, M. Harada, Y. Sasaki, H. Itoh, T. Yoshimasa, T. Namba, S. Narumiya and K. Nakao: Circ. 90, 1643-1647 (1994).
16. Y. Sasaki, T. Usui, I. Tanaka, O. Nakagawa, T. Sando, T. Takahashi, T. Namba, S. Narumiya and K. Nakao: Biochim. Biophys. Acta 1224, 601-605 (1994).
17. K.L. Pierce, D.W. Gil, D.F. Woodward and J.W. Regan: Trends Pharmacol. Sci. 16, 253-256 (1995).
18. M. Negishi, Y. Sugimoto and A. Ichikawa: Biochim. Biophys. Acta 1259, 109-120 (1995).
19. F. Ushikubi, M. Hirata and S. Narumiya: J. Lipid Mediators Cell Signal. 12, 343-359 (1995).
20. T. Ishikawa, Y. Tamai, J.M. Rochelle, M. Hirata,T. Namba, Y Sugimoto, A. Ichikawa, S. Narumiya, M.M. Taketo and M.F. Seldin: Genomics 32, 285-288 (1996).
21. E.M. Smyth, P.V. Nestor and G.A. Fitzgerald: J. Biol. Chem. 271, 33698-33704 (1996).
22. R.J. Leigh and J. MacDermot: Br. J. Pharmacol. 85 ,237-247 (1985).
23. T. Kenakin: Pharmacol. Rev. 48, 413-463 (1996).
24. H. Wise and R.L. Jones: Trends Pharmacol. Sci. 17, 17-21 (1996).
25. R. Murray, E. Shipp and G.A. Fitzgerald: J. Biol. Chem. 265, 21670-21675 (1990).
26. T. Sawai, M. Negishi, N. Nishigaki, T. Ohno and A. Ichikawa: J. Biol. Chem. 268, 1995-2000 (1993).
27. C. Cazevieille, A. Muller, F. Meynier, N. Dutrait and C. Bonne: Neurochem. Int. 24, 395-398 (1994).
28. C. Cazevieille, A. Muller and C. Bonne: Neurosci. Lett. 160, 106-108 (1993).
29. J. Aubert, G. Ailhaud and R. Negrel: FEBS Lett. 397, 117-121 (1996).
30. R.A. Armstrong, R.A. Lawrence, R.L. Jones, N.H. Wilson and A. Collier: Br. J. Pharmacol. 97, 657-668 (1989).
31. A. Corsini, G.C. Folco, R. Fumagalli, S. Nicosia, M.A. Noe and D. Oliva: Br. J. Pharmacol. 90, 255-261 (1987).
32. J.E. Merritt, T.J. Hallam, A.M. Brown, I. Boyfield, D.G. Cooper, D.M.B. Hickey, A.A. Jaxa-Chamiec, A.J. Kaumann, M. Keen, E. Kelly, U. Kozlowski and T.J. Rink: Br. J. Pharmacol. 102, 251-259 (1991).
33. R.L. Hébert, L. Regnier and L.N. Peterson: Am. J. Physiol. 268, F145-F154 (1995).
34. E. Ragazzi, A. Chinellato. Ü. Lille, M. Lopp, M.G. Doni and G. Fassina: Gen. Pharmacol. 26, 703-709 (1995).
35. H.Wise,Y. Qian and R.L. Jones: Eur. J. Pharmacol. 278, 265-269 (1995).
36. H. Takechi, K. Matsumura, Y. Watanabe, K. Kato, R. Noyori and M. Suzuki: J. Biol. Chem. 271, 5901-5906 (1996).
37. T.P. Kenakin: J. Pharmacological Methods 13, 281-308 (1985).
38. B.J.R. Whittle, S. Moncada, K. Mullane and J.R. Vane: Prostaglandins 25, 205-223 (1983).
39. J.M. Hall and P.G. Strange: Bioscience Reports 4, 941-948 (1984).
40. P.J. Leigh, W.A. Cramp and J. MacDermot: J. Biol. Chem. 259, 12431-12436 (1984).
41. S. Seiler, C.L. Brassard, A.J. Arnold, N.A. Meanwell, J.S. Fleming and S.L. Keely Jr: J. Pharm. Exp. Ther. 255, 1021-1026 (1990).
42. S.M. Seiler, C.L. Brassard, M.E. Federici, J.O. Buchanan, G.B. Zavoico, J.S. Fleming and N.A. Meanwell: Thromb. Res. 74, 115-123 (1994).
43. N.A. Meanwell, J.L. Romine, M.J. Rosenfeld, S. W. Martin, A.K. Trehan, J.J.K. Wright, M.F. Malley, J.Z. Gougoutas, C.L. Brassard, J.O. Buchanan, M.E. Federici, J.S. Fleming, M. Gamberdella, K.S. Hart, G.B. Zavoico and S.M. Seiler: J. Med. Chem. 36, 3884-3903 (1993).
44. K. Matsumura, Y. Watanabe, H. Onoe and Y. Watanabe: Neurosci. 65, 493-503 (1995).
45. H.J. Exner and E. Schlicker: Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 46-52 (1995).
46. H. Oida, T. Namba, Y. Sugimoto, F. Ushikubi, H. Ohishi, A. Ichikawa and S. Narumiya: Br. J. Pharmacol. 116, 2828-2837 (1995).
47. K.R. Bley, D.G. Blissard, S.M. Amagasu and R.M. Eglen: Prostaglandins Leuk. Essen. Fatty Acids 55, S1, p159 (1996).
48. M. Suzuki, K. Kato, R. Noyori, Y. Watanabe, K. Takechi, K. Matsumura and B. Långström: Angew. Chem. Int. Ed. Engl. 35, 334-336 (1996).
49. A.S. Milton: Ann. N Y Acad. Sci. 604, 392-410 (1990).
50. K. Yamashita, Y. Kataoka, M. Nakashima, Y. Yamashita, H. Tanabe, H. Araki, M. Niwa and K. Taniyama: Jpn. J. Pharmacol. 71, 351-355 (1996).
51. T. Minagawa, K. Sakanaka, S. Inaba, Y. Sai, I. Tamai, T. Suwa and A. Tsuji: J. Pharm. Pharmacol. 48, 1016-1022 (1996).
52. M. Tanaka, C. Kojima, M. Muramatsu and H. Tanabe: Arzneimittel-Forschung 45, 967-970 (1995).
53. K. Hoshi and Y. Mizushima: Prostaglandins 40, 155-164 (1990).
54. E. Kelly, M. Keen, P. Nobbs and J. MacDermot: Br. J. Pharmacol. 99, 309-316 (1990).
55. H. Wise and B.S. Chow, in: Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research (H.Sinzinger, J.R. Vane, B.Samuelsson, R. Paoletti, P.W. Ramwell and P.Y.-K. Wong, eds.), Plenum Press, New York (in press).
56. R.A. Ross, B.A. Spengler and J.L. Biedler: J. Natl. Cancer Inst. 71, 741-749 (1983).
57. G.D. Kim, E.J. Adie and G. Milligan: Eur. J. Biochem. 279, 135-143 (1994).
58. G.D. Kim, I.C. Carr and G. Milligan: Biochem. J. 308, 275-281 (1995).
59. A. Krane, J. MacDermot and M. Keen: Biochem. Pharmacol. 47, 953-959 (1994).
60. A. Krane and M. Keen: Br. J. Pharmacol. 115, 137P (1995).
61. A. Krane and M. Keen: Br. J. Pharmacol. 115, 138P (1995).
62. M. Keen and A. Krane: Br. J. Pharmacol. 117, 72P (1996).
63. R.J.Williams and E. Kelly: Eur. J. Pharmacol. 268, 177-186 (1994).
64. D. Pearce and M. Keen: Br. J. Pharmacol. 116, 19P (1995).
65. H. Ammer and R. Schulz: Mol. Pharmacol. 43, 556-563 (1993).
66. H. Ammer and R. Schulz: Brain Res. 707, 235-244 (1996).
67. J. Luty,M. Hepworth, E. Kelly and G. Henderson: Br. J. Pharmacol. 116, 355P (1995).
68. N. Inagaki and H. Wada: Glia 11, 102-109 (1995).
69. J. Kitanaka, H. Hashimoto, M. Gotoh, K. Kondo, K. Sakata, Y. Hirasawa, M. Sawada, A. Suzumura, T.Marunouchi, T.Matsuda and A. Baba: Brain Res. 707, 282-287 (1996).
70. S. Murphy, J. Jeremy, B. Pearce and P. Dandona: Neurosci. Letts. 61, 61-65 (1985).
71. S.A. Moore, P.H. Figard, A.A. Spector and M.N. Hart: Ann. N Y Acad. Sci. 604, 471-473 (1990).
72. K.U. Malik and E. Sehic: Ann. N Y Acad. Sci. 640, 222-236 (1990).
73. R. Gonzales, CD. Sherbourne, M.E. Goldyne and J.D. Levine: J. Neurochem. 57, 1145-1150 (1991).
74. K. Yamagata, K. I. Andreasson, W.E. Kaufmann, C. A. Barnes and P.F. Worley: Neuron 11, 371-386 (1993).
75. C. Cao, K. Matsumura, K. Yamagata and Y. Watanabe: Brain Res. 697, 187-196 (1995).
76. J. de Belleroche, J. Adams and Y. Collaço-Moraes: Prostaglandins Leuk. Essen. Fatty Acids 55, S1, p32 (1996).
77. Y. Collaço-Moraes, B. Aspey, M. Harrison and J. de Belleroche: J. Cerebral Blood Flow and Metabolism 16, 1366-1372 (1996).
78. C. Cao, K. Matsumura, K. Yamagata and Y, Watanabe: Brain Res. 733, 263-272 (1996).
79. B.L. Fiebich, K. Biber, K. Lieb, D. van Calker, M. Berger, J. Bauer and P.J. GebickeHaerter: Glia 18, 152-160 (1996).
80. M. Kawasaki, Y. Yoshihara, M. Yamaji and Y. Watanabe: Mol. Brain Res. 19, 39-46 (1993).
81. G. Hertting and A. Seregi: Ann. N Y Acad. Sci. 604, 84-99 (1990).
82. P.C. Huttemeier, Y. Kamiyama, M.Su, W.D. Watkins and H. Benveniste: Prostaglandins 45, 177-187 (1993).
83. C.W. Leffler and H. Parfenova: Am. J. Physiol. 41, H418-H424 (1997).
84. G. Hertting and A. Seregi, in: Arachidonic Acid Metabolism in the Nervous System (A.I. Barkai and N.G. Bazan,eds.), New York Academy of Science, New York (1989), pp. 84-99.
85. R.P. White: Ann. N Y Acad. Sci. 604, 131-145 (1990).
86. E. Shohami, Y. Shapira, G. Yadid, S. Cotev and G. Feuerstein: Ann. N Y Acad. Sci. 604, 485-487 (1990).
87. B.M. Djuričić, V.S. Kostic and B.B. Mršulja: Ann. N Y Acad. Sci. 604, 435-437 (1990).
88. J. A. Yergey, N. Salem Jr, J.W. Karanian, M. Linnoila and M.P. Heyes: Ann. N Y Acad. Sci. 604, 497-499 (1990).
89. J.C.S. Breitner: Annu. Rev. Med. 47, 401-411 (1996).
90. J. O'Grady, S. Warrington, M.J. Moti, S. Bunting, R.J. Flower, A.S.E. Fowle, E. A. Higgs and S. Moncada, in: Prostacyclin (J.R. Vane and S. Bergström, eds.), Raven Press, New York (1979), pp. 409-417.
91. T. Frieling, C. Rupprecht, G. Dobreva, D. Häussinger and M. Schemann: Pflugers Archiv. 437, 212-220 (1996).
92. R.M. Gaion and M. Trento: Br. J. Pharmacol. 80, 279-286 (1983).
93. R.L. Jones and R.A. Lawrence: Regul. Pept. S1, S83 (1992).
94. Y. Qian and R.L. Jones: Br. J. Pharmacol. 115, 163-171 (1995).
95. R.L. Jones, Y. Qian, F.S.F. Tam, K. Chan, J.K.S. Ho and J.-P. Bourreau: Neuronal stimulant actions of prostacyclin and its novel mimetics, in: Eicosanoids and Other Bio-active Lipids in Cancer, Inflammation and Radiation Injury 3 (K. V. Honn, R.L. Jones, L.J. Marnette, S. Nigam and P.Y.-K. Wong, eds.), Plenum Press, New York (1997), 211-217.
96. H. Wise: Prostaglandins Leuk. Essen. Fatty Acids 54, 351-360 (1996).
97. R.A. Armstrong, R.L. Jones, J. MacDermot and N.H. Wilson: Br. J. Pharmacol. 87, 543-551 (1986).
98. R.L. Jones: Br. J. Pharmacol. 108, 16P (1993).
99. A.M. McKay and N.L. Poyser: Br. J. Pharmacol. 176, 2679-2684 (1995).
100. F.S.F. Tam, K. Chan, J.-P. Bourreau and R.L. Jones: Br. J. Pharmacol. (in press).
101. G. Molderings, B. Malinowska and E. Schlicker: Br. J. Pharmacol. 107, 352-355 (1992).
102. G.J. Molderings, E. Colling, J. Likungu, J. Jakschik and M. Göthert: Br. J. Pharmacol. 111, 733-738 (1994).
103. B. Malinowska, G. Godlewski, W. Buczko and E. Schlicker: Eur. J. Pharmacol. 259, 315-319 (1994).
104. R. Uda, S. Horiguchi, S. Ito, M. Hyodo and O. Hayaishi: Brain Res. 510, 26-32 (1990).
105. S.H. Ferreira, M. Nakamura and M.S.A. Castro: Prostaglandins 16, 31-37 (1978).
106. Y.O.Taiwo, L. Bjerknes, E.J. Goetzl and J.D. Levine: Neurosci. 32, 577-580 (1989).
107. N.S. Doherty, T.H. Beaver, K.Y. Chan, J.E. Coutant and G.L. Westrich: Br. J. Pharmacol. 91, 39-47 (1987).
108. K. Tanaka, T. Shimotori, S. Makino, M. Eguchi, K. Asaoka, R. Kitamura and C. Yoshida: J. Pharmacobio-Dyn. 15, 641-647 (1992).
109. M. Katori, Y. Hori, Y. Uchida, K. Tanaka and Y. Harada: Adv. Exp. Med. Biol. 198, 393-398 (1986).
110. S.H. Ferreira and M. Nakamura: Prostaglandins 18, 191-200 (1979).
111. S.H. Ferreira and M. Nakamura: Prostaglandins 18, 201-208 (1979).
112. G.L. Birrell and D.S. McQueen: Brain Res. 611, 103-107 (1993).
113. C.M. Hingtgen and M.R. Vasko: Brain Res. 655, 51-60 (1994).
114. T. Minami, I. Nishihara, R. Uda, S. Ito, M. Hyodo and O. Hayaishi: Br. J. Pharmacol. 112, 735-740 (1994).
115. Y.O. Taiwo and J.D. Levine: Brain Res. 458, 402-406 (1988).
116. Y.O. Taiwo and J.D. Levine: Brain Res. 492, 397-399 (1989).
117. A. Dray: News Physiol. Sci. 11, 288-292 (1996).
118. K. Matsumura, Y. Watanabe, H. Onoe, S. Tanaka, T. Shiraki and S. Kobayashi: Brain Res. 626, 343-346 (1993).
119. K. Mori, S. Oka, A. Tani, S. Ito and Y. Watanabe: Biochem. Biophys. Res. Commun. 162, 1535-1540( 1989).
120. G. Siegel, A. Carl, A. Adler and G. Stock: Eicosanoids 2, 213-222 (1989).
121. W.F. Jackson, A. König, T. Dambacher and R. Busse: Am. J. Physiol. 264, H238-H243 (1993).
122. S.H. Ferreira and M. Nakamura: Prostaglandins 18, 179-190 (1979).
123. CM. Hingtgen, K.J. Waite and M.R. Vasko: J. Neurosci. 15, 5411-5419 (1995).
124. T.H. Hintze: Fed. Proc. 46, 73-80 (1987).
125. J. Staszewska-Barczak: Am. J. Cardiol. 52, 36A-45A (1983).
126. J. Tamaoki, A. Chiyotani, K. Takeyama, F. Yamauchi, E. Tagaya and K. Konno: Prostaglandins 45, 363-373 (1993).